The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.
from CNN.com - RSS Channel - App International Edition https://ift.tt/3728sWh
via IFTTT
Subscribe to:
Post Comments (Atom)
-
Executive and mother-of-five Sarah Dougan faces a difficult choice: risk her new life and fortune to face justice in Australia or being kick...
-
Jade Brooks had about 10 people fall on her during a "crowd crush" at the Cornwall event, she says. from BBC News https://ift.tt...
-
“After visiting Alhambra as a young backpacker in 1982, I looked forward to my return visit to take in what I had not fully appreciated at t...
No comments:
Post a Comment